OPTIMIERTE SEQUENZIERUNG KLINISCHER PROBEN

European patent · EP3325697 · In force

Register entry

Publication number
EP3325697
Application number
EP16742239
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 19, 2016
Published
May 30, 2018
Granted
Nov 10, 2021
Protection ends at the latest
Jul 18, 2036
Next annual fee due
Jul 31, 2027
IPC classes
C12Q 1/6869 (2018.01)
C12Q 1/686 (2018.01)
C12Q 1/6851 (2018.01)
G01N 35/00 (2006.01)
C40B 60/06 (2006.01)
Priority
EP 15178159 23.07.2015
PCT application
PCT/EP2016/067148 19.07.2016
PCT publication
WO2017/013102 26.01.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Sep 21, 2022

    Change

    Published in Swissreg on 21.09.2022

  6. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  7. Nov 10, 2021

    Granted

    Published in Swissreg on 10.11.2021

Parties

Holder

Biocartis NV

Generaal De Wittelaan 11 B3, 2800 Mechelen, BE

Inventor

VERGAUWE, Nicolas

2800 Mechelen, BE

MEERSSEMAN, Geert

2800 Mechelen, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.